The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: Signalling pathway and novel therapeutic targets

Iring, András [Iring, András (Élettan), author] Laboratory of Molecular Pharmacology (IEM / DP); Tóth, Adrián [Tóth, Adrián (Neurológia), author] Laboratory of Molecular Pharmacology (IEM / DP); Department of Neurology (SU / FM / C); Baranyi, Mária [Baranyi, Mária (Molekuláris farma...), author] Laboratory of Molecular Pharmacology (IEM / DP); Otrokocsi, Lilla [Bereczkiné Otrokocsi, Lilla (élettudomány), author] Laboratory of Molecular Pharmacology (IEM / DP); Módis, László V. [Módis, László (V. Módis László), author] Department of Neurology (UD); Gölöncsér, Flóra [Gölöncsér, Flóra (idegtudományok), author] Laboratory of Molecular Pharmacology (IEM / DP); Varga, Bernadett [Varga, Bernadett (funkcionális ideg...), author] Laboratory of Molecular Pharmacology (IEM / DP); School of PhD Studies (SU); Hortobágyi, Tibor [Hortobágyi, Tibor (Neuropathológia), author] Department of Pathology (SZTE / ASZMS); Department of Neurology (UD); Bereczki, Dániel [Bereczki, Dániel (Stroke), author] Department of Neurology (SU / FM / C); Dénes, Ádám [Dénes, Ádám (Neurobiológia, ne...), author] Laboratory of Neuroimmunology; Sperlágh, Beáta ✉ [Sperlágh, Beáta (Neurofarmakológia), author] Laboratory of Molecular Pharmacology (IEM / DP); School of PhD Studies (SU)

English Article (Journal Article) Scientific
Published: PHARMACOLOGICAL RESEARCH 1043-6618 1096-1186 176 Paper: 106045 , 16 p. 2022
  • SJR Scopus - Pharmacology: D1
Identifiers
Fundings:
  • Hungarian Research and Develop-ment Fund(116654)
  • Hungarian Research and Develop-ment Fund(131629)
  • Hungarian Brain Research Program(2017-1.2.1-NKP-2017-00002)
  • Hungarian Academy of Sciences Premium Postdoctoral Research Program(PPD2019-20/2019-439.)
Subjects:
  • Pharmacology, pharmacogenomics, drug discovery and design, drug therapy
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-01 22:16